COSCIENS Biopharma Inc. (TSX:CSCI)

Canada flag Canada · Delayed Price · Currency is CAD
2.010
-0.100 (-4.74%)
At close: Mar 6, 2026
-49.37%
Market Cap 6.40M
Revenue (ttm) 12.61M
Net Income (ttm) -20.76M
Shares Out 3.18M
EPS (ttm) -6.58
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,600
Average Volume 2,117
Open 2.220
Previous Close 2.110
Day's Range 2.010 - 2.220
52-Week Range 2.010 - 6.460
Beta 1.17
RSI 24.50
Earnings Date Mar 25, 2026

About COSCIENS Biopharma

COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a chewable for cholesterol reduction; beta glucan from yeast, a nutraceutical-capsule used as an immune booster; and avenanthramides, a nutraceutical-chewable formulation used to reduce... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1990
Employees 40
Stock Exchange Toronto Stock Exchange
Ticker Symbol CSCI
Full Company Profile

Financial Performance

In 2024, COSCIENS Biopharma's revenue was $9.59 million, an increase of 34.22% compared to the previous year's $7.14 million. Losses were -$15.31 million, 339.3% more than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.